NCT07013201 - A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis | Biotech Hunter

Enrollment

135

Participants

Timeline

Start Date

September 11, 2025

Primary Completion Date

December 14, 2026

Study Completion Date

December 14, 2026

Conditions

Palmoplantar Pustulosis

Interventions

DRUG

Delgocitinib cream

Topical application

DRUG

Vehicle cream

Topical application

Trial Locations (21)

19103

RECRUITING

LEO Pharma Investigational Site, Philadelphia

23562

RECRUITING

LEO Pharma Investigational Site, Lübeck

30135

RECRUITING

LEO Pharma Investigational Site, Douglasville

44124

RECRUITING

LEO Pharma Investigation Site, Mayfield Heights

RECRUITING

LEO Pharma Investigational Site, Mayfield Heights

48455

RECRUITING

LEO Pharma Investigational Site, Bad Bentheim

49074

RECRUITING

LEO Pharma Investigational Site, Osnabrück

68167

RECRUITING

LEO Pharma Investigational Site, Manheim

92708

RECRUITING

LEO Pharma Investigational Site, Fountain Valley

V3R 6A7

RECRUITING

LEO Pharma Investigational Site, Surrey

L8L 3C3

RECRUITING

LEO Pharma Investigational Site, Hamilton

L8N 1Y2

RECRUITING

LEO Pharma Investigational Site, Hamilton

L3P 1X2

RECRUITING

LEO Pharma Investigational Site, Markham

H2X 2V1

RECRUITING

LEO Pharma Investigational Site, Montreal

15-879

RECRUITING

LEO Pharma Investigational Site, Bialystok

38-440

RECRUITING

LEO Pharma Investigational Site, Iwonicz-Zdrój

90-436

RECRUITING

LEO Pharma Investigational Site, Lodz

20-011

RECRUITING

LEO Pharma Investigational Site, Lublin

35-055

RECRUITING

LEO Pharma Investigational Site, Rzeszów

02-482

RECRUITING

LEO Pharma Investigational Site, Warsaw

50-566

RECRUITING

LEO Pharma Investigational Site, Wroclaw